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A recombinant His-Vi protein of Salmonella enterica serovar Typhi was successfully constructed and 
cloned into an expression vector through a nucleotide-nucleotide hybridization approach. After 
transformation of the construct into Escherichia coli, the recombinant His-Vi protein with a size of 
approximately 4 kDa was successfully produced and proven by Western blot analysis. This 
recombinant protein can be used to detect specific anti-Vi antibody produced by typhoid patients. 
Overall, the His-Vi recombinant protein could serve as a potential diagnostic reagent to detect S. Typhi 
infection in an individual.  
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INTRODUCTION 
 
Typhoid fever, a disease caused by Salmonella enterica 
serovar Typhi remains an important infectious disease 
problem in many developing countries around the world. 
The global annual incidence is estimated at 22 million 
cases with more than 200 thousand deaths per year 
(Crump et al., 2004). Transmission of typhoid fever is 
mainly through consumption of food or water contami-
nated with feces or through contact with carriers. Chlo-
ramphenicol, amoxicillin, trimethoprim-sulfamethoxazole 
represent the first-line drugs for treatment of typhoid 
fever. However, the emergence of multidrug resistant S. 
Typhi with additional resistance to fluoroqui-nolones has 
drastically reduced treatment options. Vaccination is 
indicated for high-risk individuals, such as travelers to 
typhoid outbreak countries, persons with intimate 
exposure to carriers and laboratory personnel (Deroeck 
et al., 2008). 
The capsular polysaccharide Vi antigen (ViCPS) is an 
essential virulence factor and also a protective antigen of 
S. Typhi. ViCPS is involved in  immune  response  during  
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infection of human host. Anti-Vi CPS antibodies are 
elicited during a naturally acquired infection with S. Typhi 
(House et al., 2008) and have been used to identify 
carriers of S. Typhi (Nolan et al., 1980). We have pre-
viously isolated two populations of phages that react with 
both Vi monoclonal antibody and polyclonal sera from 
typhoid patients (Tang et al., 2003). The potential use of 
these phage-displayed peptides as a diagnostic reagent 
to detect antibodies in sera from patients with confirmed 
typhoid fever was evaluated by a phage-ELISA assay 
and these peptides carry mimotopes to ViCPS (Thong et 
al., 2007).  In this study, we cloned and expressed the Vi 
mimotope in an expression vector and analyzed by 
Western blot.  The amino acid sequence information was 
obtained from previous study (Tang et al., 2003). Overall, 
the expressed Vi mimotope with a His tag could be 
served as a potential protein for screening of S. Typhi 
infection. 
 
 
METHODOLOGY 
 
The Vi mimotope of S. enterica serovar Typhi was successfully con-
structed through nucleotide-nucleotide hybridization approach in 
this study. The annealed nucleotides were further cloned into the 
pCANTAB5E  vector  and  formed pCANTAB5EHis-Vi  construct  as  
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Figure 1. The  pCANTAB5EHis-Vi  construct.  Two oligonucleotides (Sfi-His-Vi: 
5’-CGGCCATGCATCACCATCACACGAGTCATCATGATTCTCATGGTCTTCATCGT 
GTTGC-3’ and Not-Vi: 5’-GGCCGCAACACGATGAAGACCATGAGAATCATGAT 
GACTCGTGTGATGGTGATGGTGATGCATGGCCGGCT-3’) encoding the His-Vi 
antigen (Invitrogen) were designed based on the previously published mimotope 
sequence, TSHHDSHGLHRV. The construct was formed by nucleotide-nucleotide 
hybridization approach and further ligated into an expression vector.   The ligation 
reaction mixture was prepared by combining the phosphorylated pCANTAB 5E 
expression vector with hybridized oligonucleotide product. 
 
 
 
shown in Figure 1. The construct was successfully transformed into 
E. coli HB 2151 as it produced the desired recombinant His-Vi 
protein following induction. Western blot analysis using anti-
6xHis-AP as the detection antibody revealed that the expressed 
His-Vi protein was about 4 kDa protein. Finally, functional study of 
the His-Vi recombinant protein was carried out by applying the 
recombinant protein onto 12 serum samples (8 serum samples 
from typhoid patients and another 4 serum samples from healthy 
individuals) that immobilized on a nitrocellulose membrane. A 
comparison  study using synthesized TSHHDSHGLHRV-AP and 4 
serum samples (2 serum samples from typhoid patients and 
another 2 serum samples from healthy controls) was also carried 
out.   
 
 
RESULTS AND DISCUSSION  
 
The overall results showed that the His-Vi recombinant 
protein can be used to detect the typhoid patient serum. 
The results are shown in Figure 2. 
S. Typhi strains isolated from the blood of patients with 
typhoid fever invariably possess this antigen and Vi-
positive strains are more virulent than Vi-negative mu-
tants on the basis of experiments conducted on human 
volunteers (Hashimoto et al., 1993). In previous study, a 
12 mers of S. Typhi Vi mimotope has been identified by 
biopanning against a ViCPS-specific monoclonal anti-
body, mAb ATVi (Tang et al., 2003). The sequence was 
also obtained in a similar panning process by using sera 
from patients with a confirmed diagnosis of typhoid fever, 
suggesting they mimic immunodominant epitopes of Vi 
antigens.  
In this study, the desired His-Vi recombinant protein 
was expressed in E. coli HB 2151. In this E. coli strain, 
protein synthesis is aborted at the end of the recombinant 
sequence due to recognition of a stop codon. As a result, 
the recombinant His-Vi protein is transported and accu-
mulates in the periplasmic space of the bacteria until a 
critical level, after which the soluble recombinant will leak 
into the culture medium (Hoogenboom et al., 1991). 
Hence   the   desired   recombinant   protein   is  not  only   
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Figure 2. Western dot blot. (A) A nitrocellulose membrane was dotted with serum from typhoid patients (single arrow) 
and healthy individuals (double arrows) followed by the detection using recombinant His-Vi protein as the primary 
antibody and anti-6xHis-AP antibody as the secondary antibody. The result shows only sera from typhoid patients 
was specifically detected by the expressed recombinant His-Vi protein. (B) Similar result was obtained when 
synthesized TSHHDSHGLHRV-AP was used as the detection ligand.    
 
 
 
obtained in the periplasmic extract of induced bacterial 
cells, very likely it could also be extracted from the culture 
medium. The extracted recombinant His-Vi proteins are 
small in size (4 kDa). Generally, there is a problem for 
small peptides to be expressed in a bacterial system 
since the peptide may not be stable and can easily 
degraded by the bacteria. However, such problem is 
minimized in this case since the peptide was fused to 
His-tag at the 5’ end and another E-tag from the vector at 
the 3’ end. However, the yield of the expressed peptide 
may be greatly enhanced in future if the peptide is fused 
to a carrier protein or linked together as a large tandem 
polymer of repeated units as described by other study 
(Kuliopulos et al., 1987). 
Figure 2 shows both the extracted recombinant His-Vi 
proteins and the synthesized TSHHDSHGLHRV-AP have 
binding affinity towards the typhoid patient serum that 
dotted onto 2 separate nitrocellulose membranes. In 
order to extract the recombinant Vi protein from the bac-
terial cells, BugBuster protein extraction reagent (Nova-
gen) was used in this study. This reagent disrupts of the 
E. coli cell wall to liberate active proteins. It provides a 
simple, rapid and low-cost method for releasing expres-
sed target proteins. 
In conclusion, a His-Vi recombinant protein was ex-
pressed in E. coli HB 2151 was successfully obtained. 
Further works on sensitivity and specificity tests with 
more samples should be carried out to explore the appli-
cation of this reagent for rapid detection of Vi antibodies 
in persons with suspected typhoid fever. This is important 
because it could be an alternative choice of typhoid 
detection besides Widal test since the later cannot be 
expected to give an absolutely reliable diagnostic result in  
endemic areas (Olopoenia and King, 2000). 
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